• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝对中性粒细胞计数可预测肿块型肝内胆管癌的术后预后。

Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma.

作者信息

Watanabe Akira, Harimoto Norihumi, Araki Kenichiro, Kubo Norio, Igarashi Takamichi, Tsukagoshi Mariko, Ishii Norihiro, Yamanaka Takahiro, Yoshizumi Tomoharu, Shirabe Ken

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.

Department of Hepatobiliary and Pancreatic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan

出版信息

Anticancer Res. 2019 Feb;39(2):941-947. doi: 10.21873/anticanres.13197.

DOI:10.21873/anticanres.13197
PMID:30711979
Abstract

BACKGROUND/AIM: Intrahepatic cholangiocarcinoma (IHCC) is characterized by poor prognosis, and postoperative recurrence remains a problem. Thus, prognostic markers for IHCC are greatly needed. Recently, inflammatory factors were reported to be related to tumor progression and recurrence in various cancers. Therefore, the present study aimed to evaluate the prognostic ability of inflammatory factors.

MATERIALS AND METHODS

Forty-four patients with mass-forming IHCC (m-IHCC) were retrospectively evaluated and the correlations between inflammatory markers, including neutrophil-to-lymphocyte ratio and, modified Glasgow prognostic score, and patient survival were assessed.

RESULTS

The absolute neutrophil count (ANC) was significantly higher in the recurrence group than in the non-recurrence group (p=0.00568) and the most significant prognostic factor by multivariate analysis. Poor recurrence-free survival (RFS; p=0.00452) and cancer-specific survival (CSS; p=0.0323) were associated with high neutrophil levels. Moreover, neutrophil infiltration in the tumor site was positively correlated with ANC.

CONCLUSION

ANC is associated with poor RFS, and could be used to predict recurrence in patients with m-IHCC.

摘要

背景/目的:肝内胆管癌(IHCC)预后较差,术后复发仍是一个问题。因此,非常需要IHCC的预后标志物。最近,有报道称炎症因子与各种癌症的肿瘤进展和复发有关。因此,本研究旨在评估炎症因子的预后能力。

材料与方法

回顾性评估44例肿块型IHCC(m-IHCC)患者,评估炎症标志物(包括中性粒细胞与淋巴细胞比值和改良格拉斯哥预后评分)与患者生存率之间的相关性。

结果

复发组的绝对中性粒细胞计数(ANC)显著高于未复发组(p = 0.00568),且是多因素分析中最显著的预后因素。中性粒细胞水平高与无复发生存期(RFS;p = 0.00452)和癌症特异性生存期(CSS;p = 0.0323)差相关。此外,肿瘤部位的中性粒细胞浸润与ANC呈正相关。

结论

ANC与较差的RFS相关,可用于预测m-IHCC患者的复发。

相似文献

1
Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma.绝对中性粒细胞计数可预测肿块型肝内胆管癌的术后预后。
Anticancer Res. 2019 Feb;39(2):941-947. doi: 10.21873/anticanres.13197.
2
The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.术前中性粒细胞与淋巴细胞比值升高预示着接受肝切除术的肝内胆管癌患者预后不良。
Tumour Biol. 2015 Jul;36(7):5283-9. doi: 10.1007/s13277-015-3188-6. Epub 2015 Feb 12.
3
The Prognostic Impact of Leucine-Rich α-2-Glycoprotein-1 in Cholangiocarcinoma and Its Association With the IL-6/TGF-β1 Axis.富含亮氨酸的α-2-糖蛋白-1在胆管癌中的预后影响及其与IL-6/TGF-β1轴的关联
J Surg Res. 2020 Aug;252:147-155. doi: 10.1016/j.jss.2020.03.018. Epub 2020 Apr 9.
4
Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.中性粒细胞与淋巴细胞比值升高和肝内胆管细胞癌为主型与合并肝细胞癌-胆管细胞癌患者肝切除术后不良结局相关。
PLoS One. 2020 Dec 11;15(12):e0240791. doi: 10.1371/journal.pone.0240791. eCollection 2020.
5
The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma.微血管密度在肝内胆管癌中的预后意义
J Med Assoc Thai. 2010 Jan;93(1):66-72.
6
Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.再次手术治疗肝内胆管细胞癌患者首次肝切除术后复发的效果。
Int J Clin Oncol. 2020 Dec;25(12):2083-2089. doi: 10.1007/s10147-020-01775-x. Epub 2020 Aug 31.
7
Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.肝内胆管癌根治性切除术后的局部区域复发:辅助放疗的意义
Clin Transl Oncol. 2015 Oct;17(10):825-9. doi: 10.1007/s12094-015-1312-0. Epub 2015 Jun 4.
8
Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.术前中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对肝外胆管癌患者生存的影响
Anticancer Res. 2017 Jun;37(6):3229-3237. doi: 10.21873/anticanres.11685.
9
Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.肝内胆管癌根治性肝切除术后复发的预测因素及模式,用于术后放疗:一项回顾性研究
World J Surg Oncol. 2015 Jul 29;13:227. doi: 10.1186/s12957-015-0637-z.
10
Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis.淋巴结阴性肝内胆管癌的预后因素,特别提及血管生成
Am J Surg. 2004 Apr;187(4):538-42. doi: 10.1016/j.amjsurg.2003.12.044.

引用本文的文献

1
Target neutrophil heterogeneity and plasticity in cancer.癌症中目标中性粒细胞的异质性和可塑性。
J Hematol Oncol. 2025 Aug 12;18(1):79. doi: 10.1186/s13045-025-01731-0.
2
A multi-algorithm prognostic model combining inflammatory indices and surgical features in distal cholangiocarcinoma.一种结合炎症指标和手术特征的远端胆管癌多算法预后模型。
Front Oncol. 2025 Jul 21;15:1625703. doi: 10.3389/fonc.2025.1625703. eCollection 2025.
3
A Cohort Study on Dual Predictive Markers of Immune Combination Therapy for Advanced Non-Small Cell Lung Cancer.
一项关于晚期非小细胞肺癌免疫联合治疗双重预测标志物的队列研究。
Biomark Insights. 2025 Feb 14;20:11772719251319641. doi: 10.1177/11772719251319641. eCollection 2025.
4
Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on "Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma".间质学:预测胆管癌复发:关于“用于预测肝内胆管癌预后的间质-免疫特征的开发与验证”的社论
Clin Mol Hepatol. 2025 Jan;31(1):323-326. doi: 10.3350/cmh.2024.0932. Epub 2024 Oct 29.
5
The potential of cancer stem cells for personalized risk assessment and therapeutic intervention in individuals with intrahepatic cholangiocarcinoma.癌症干细胞在肝内胆管癌患者个性化风险评估和治疗干预中的潜力。
Discov Oncol. 2024 Jul 24;15(1):306. doi: 10.1007/s12672-024-01179-7.
6
Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma.基于可解释机器学习的临床预测模型,用于预测肝内胆管细胞癌患者的淋巴结转移。
BMC Gastroenterol. 2024 Apr 19;24(1):137. doi: 10.1186/s12876-024-03223-w.
7
A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma.一种新型术前炎症评分系统,用于预测肝内胆管癌的术后预后。
BMC Cancer. 2023 Feb 24;23(1):188. doi: 10.1186/s12885-023-10668-x.
8
Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients.系统免疫炎症指数在胆道癌中的预后作用:3515 例患者的荟萃分析。
World J Surg Oncol. 2022 Sep 29;20(1):320. doi: 10.1186/s12957-022-02783-z.
9
Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta-analysis.术前炎症标志物对肝切除术后肝内胆管细胞癌患者预后的预测价值:系统评价和荟萃分析。
Cancer Med. 2023 Jan;12(1):99-110. doi: 10.1002/cam4.4935. Epub 2022 Jun 12.
10
Neutrophils in cancer carcinogenesis and metastasis.中性粒细胞在癌症发生和转移中的作用。
J Hematol Oncol. 2021 Oct 21;14(1):173. doi: 10.1186/s13045-021-01187-y.